Jane Zhang: Scalable AI in Pediatrics

On this episode of The Founder's Sandbox, Brenda speaks with Jane Zhang, CEO and Founder of Remmie Health about Scalable AI in Pediatrics. Jane progressed through her professional career as Biomedical Engineer, PhD Adjunct Professor, Big Pharma and it was upon living a very personal situation that she wanted be become a “builder": entrepreneurship was calling her. 

Listen to Jane’s podcast, as she shares where this whole idea of building something for the people at home to be able to examine, share, and, in the future - get assistance in identifying ENT diseases- became very important to her. Jane shares how she has built a product and services for at home examinations of the ear, nose, and throat and her real experience of developing a FDA approved Class 1 device, now in clinical trials. 

Remmie 3 is a FDA-registered and CE Marked next generation intelligent otoscope designed for patients of all ages.

You can find out more about Jane and Remmie Health at:

https://www.linkedin.com/in/janeyzhang

https://medium.com/@janeyqz/my-experience-with-my-sons-recurring-ear-infections-a-3-part-story-fdbc4ea0016e

https://remmiehealth.com/  

https://www.linkedin.com/company/remmiehealth/

Remmie was present at MEDICA 2024, the most important international fair dedicated to medicine and hospital technology. The event will took place in Düsseldorf, Germany, from 11 to 14 November 2024.

https://www.ca-mi.eu/en/germany/01/2024/medica-dusseldorf-11-14-november-2024/

and at the American Speech-Language-Hearing Association 2024 ASHA Convention from December 5-7 in Seattle, Washington.

https://convention.asha.org/

 

 

 

Transcript: 

00:04
Hi, I'm pleased to announce something very special to me, a new subscription-based service through Next Act Advisors that allows members exclusive access to personal industry insights and bespoke

00:32
corporate governance knowledge. This comes in the form of blogs, personal book recommendations, and early access to the founder's sandbox podcast episodes before they released to the public. If you want more white glove information on building your startup with information like what was in today's episode, sign up with the link in the show notes to enjoy being a special member of Next Act Advisors.

01:01
As a thank you to Founders Sandbox listeners, you can use code SANDBOX25 at checkout to enjoy 25% off your membership costs. Thank you.

01:18
Welcome back to the Founders Sandbox. I am Brenda McCabe, your host. This is a monthly podcast in which I reach entrepreneurs, business owners, and I have as my guest, entrepreneurs and business owners, professional service providers, and corporate board directors who bring their own stories about building resilient, purpose-driven, and sustainable businesses with great corporate governance.

01:47
I want to assist entrepreneurs and entrepreneurs in building those scalable, well-governed and resilient businesses. And by bringing my guests to the podcast, they too want to use the power of the enterprise, small, medium and large to create change for a better world. We're going to tell stories in this podcast today. And my guest is Jane Zhang. She's CEO of Remmie and she's joining us here from the state of Washington.

02:17
Jane and I go back almost, I don't know, four or five years now. Jane was at the UCLA MedTech competition. She had just founded Remmie in 2018 and then actually put some bones around it and financing into 2020 was actually seeking external investment dilutive type. And I couldn't help.

02:46
but remember Jane's origin story of why she started Remmie. And we're gonna start with that. So Jane, I would love for you to walk down memory lane with me and go back to when we met in the campus at the UCLA MedTech. And what was your origin story? Yeah, Brenda, I really appreciate this opportunity and thank you for the great intro. It was.

03:14
It was unforgettable why I, every day I'm reminded of why I'm on this mission because my own son, who was a preschooler back then, had recurring ear, nose and throat issues, especially ear infections. It was basically nonstop. A lot of the weekends, my colleagues would ask me, what are you doing on the weekend? I'd be like,

03:43
My son is having a fever I'm taking next week off. So it happened four times. In the first year he went to childcare. And one of the times he had a high fever, we went to the ER and it took us four hours sitting there nonstop with his crying and screaming. And the other times we were referred to an ENT specialist who was about to put in ear tubes in his ears. And other times we were

04:12
misdiagnosed because he had air nose and hands with mouse disease where we were given antibiotics. I give him 10 days and he's still spiking a fever. It keeps on coming back. And the doctor said there was a it was a moment of revelation where this physician, my pediatrician told me, come, come take a look by yourself. I was like, what? Why? And he said the throat or the back of his throat was all white blisters. So this was not an air infection.

04:43
um who gave you antibiotics that was the question he asked me he said you should be able to look by yourself and why weren't you doing that i was like what really i'm a bio medical engineer by training by the way um especially in low resource setting diagnostics or like basically home home diagnostic kits um he asked me why aren't you looking by yourself i was like what am i supposed to look uh and with what

05:11
So that's where this whole idea of building something for the people at home to be able to examine, share, and in the future getting assistance in identifying ENT diseases became very important to me. Wow. So you had at that time been working

05:36
for a large pharmaceutical company. As you said, you are a biomedical engineer by training, and you just completed your executive MBA, I think at UCLA. So what made you make the jump? One thing is going to the emergency room with your child time and time again. You talked about your aha moment and how can I in a low resource, right? At home.

06:03
be able to actually diagnose and actually treat my child. What happened that made you want to actually become an entrepreneur, Jane? One thing is working on the research side, but becoming an entrepreneur, what made you do that? It was very, so it was like everything kind of lined up in a way, and it just, my background, I was an engineer by training.

06:32
I worked as a scientist, you know, like in all the way up to postdoctoral level research. And then I took a turn into getting more into product development, business development, and commercial operations, because I thought that was really going to help me broaden my vision of the my view of how things work, you know, that I'm basically a curiosity driven person.

06:57
And at that point, while I was working in a big corporate, in a pharmaceutical company, I was sort of getting more experienced in a commercial side of things. I figured I had two choices, probably one, two, actually three choices I was considering, right? Like one is to go back to research and become a faculty member. In fact, I did, you know, that was kind of my way of rethinking my whole, reorienting my whole career path.

07:25
Um, the other one was going to become an investor. Um, the third was to fund my own company and just go on this path of building things. Um, I, I thought, uh, this issue of my child's problem just really was hitting at home that this is, because it's after I talked to many people, I was not alone. I'm not the only person who's going through this. Everyone I talked to said, Oh my gosh, that was me. Um,

07:54
I was like, this is a big deal. It not only impacts your child's health, it impacts your productivity at the prime time of your life when you just had the child. And it was just like really hitting a home. I had to do this after a couple of years of hiatus in academics, in academia, as a faculty member of engineering in University of Washington. After completing my MBA, in the meantime, I decided being a builder.

08:24
an entrepreneur is the calling for me. Is the path, is the path to shift. Amazing. Talk to me about the number of ENT cases that you are addressing with Remy today. Talk to me about that. I guess a striking number was 70 million in the US, both adults and children. A year, right? And it's really fast. A year. Yeah.

08:53
suffering from some ENT diseases. And this is not just specialty disease that I'm talking about, it's every day. Like anything that you have when you have a sore throat, a painful nose or ear infection or cold and flu, it impacts these organs. The first line organs being impacted are your ENT, but it doesn't stop there, right? For children, it is very highly occurring. Like if you look at the number of children who go see ENT issues, ear infections alone is...

09:22
about 24 million a year, that's 80% of any children before the age of eight or three, they've already had one ear infection, not to mention 30% have more than three a year. And adults, like when you're thinking about, sinusitis, sore throat, strapped throat, how all these impact the overall population quite a bit. So what is the solution at that?

09:50
Remy provides. You're going to walk us through kind of the, it's AI powered ENT, so ear, nose and throat health platform. It has many components. What's the patient experience today that you're attacking and how is it going to look in the future? Walk us through the product, please. Yeah. I love that way of thinking and thinking as a patient or a user of any anything that we are providing.

10:20
So you already kind of heard my journey of nonstop sort of rotation in like a spinning wheel among pediatrics office, urgent care, ENT's office, and ER, right? And then over again for another episode, if it's recurring or chronic. The experience that we're trying to provide is along the line of how the disease progresses and how physicians examine.

10:50
a quadrant or like a progression lifetime along that line. What I mean is when you first have a pain or some sort of discomfort, you would want to, you know, a doctor when they examine you, they would check, they would look, they would look with a, right now they look with an otoscope, which is a glorified flashlight plus magnifier, obviously very, very high fidelity.

11:20
That's the first step. They look, they examine. And then the second thing they do is, well, obviously you have to be in person first with the physician, right? So there's no sharing per se, which we're trying to build towards is you can look, you know, if a doctor is using an otoscope, why can't the patient be taught how to use it? It's very similar to a thermometer in a way, except it's a camera. So, you know, if a physician is looking with their eye.

11:48
we can make it digitized as a camera for patients to use at home. And if you have to be in person today, you should be able to transmit this, whatever you're looking at or collecting over the internet in terms of sharing. And then the third step of the whole diagnosis journey is basically analyze. The physician kind of asks you how you feel, they aggregate a lot of information about you, who you are, what you're going through and your physical presentation of the symptoms.

12:19
that should also be partly supported by AI. So that's kind of what I'm working towards is, it's like a million doctors supporting every single physician, every, you know, one doctor being supported by a million in terms of the insights that's used to go into their diagnosis. And did I mention that the misdiagnosis rate is about 40% on any day? Misdiagnosis meaning either, you know,

12:49
you're prescribed antibiotics where you're not, you should not have been, or you're referred to a specialist where you should not have been, or you went to the ER, because you did not receive the care in time. I guess that's a broader sense of misdiagnosis, which means you missed the opportunity for diagnosis in the proper setting. So, but that's very prevalent in terms of misdiagnosis. So we like to support anyone who's

13:17
first examining the condition with AI tools, being a patient or a primary care physician. Before we get into the AI question that I have for you, talk to me about some of the communities that can benefit from the use of an AI-powered ENT device. Yeah. I.

13:46
The first thing that comes to my mind is home users, any general lay person at home who may not have the resources to see a physician in person. It could be someone who's lack of access in a way that they are in a remote area, lack of resources to pay for healthcare, or even lack of time. Someone who is working, who has a job but just doesn't have the time to.

14:15
to see a doctor. So I would think under underserved communities, population who are at lack of resources such as time, money, or you know, driving. You know, driving is a hassle for a lot of families and just anywhere at home. Anyone who is, you know, even I was talking to a bunch of undergrad, you know, college students are like, we're so used to just sitting on our couch and see a doctor.

14:45
That's possible. And that was really the key moment when I was sitting as a judge. The first time I actually was exposed to you, Jane, met you and heard about Remy, it was the possibility that digital health, right? I'm not having to go into a doctor's office. And the digital health to use preventatively, right? To prevent disease.

15:13
diseases to progress. I think, and then, you know, AI is just an added layer on top, so that truly was a moment when I thought everybody, well, at least there's 70 million cases a year of ear, nose, and throat, what this platform may offer for other disease areas where we don't have necessarily to go into the doctor's office. So it was fascinating. That's what brought us into this relationship.

15:41
So talk to me about, we've talked about the platform, where you're going, how it's offered. What has been your founder experience? All right, you decided you took a head issue and went back to the academic world. You really wanted to become an entrepreneur, started the company. You won a competition out of UCLA, I think business case. That's about the time I met you, right? Talk to me about how the journey has been in terms of

16:10
resources, the resources that you have received, non-dilutive funding, where are you on that path, and how many healthcare systems are currently either testing or looking into the use of Remy? That's a loaded question. So talk to me about the journey of financing and where the product is being used today. Absolutely. The journey is long and very,

16:40
full of support, you know, like that's, that's a very upfront, you know, support from my very early days where my MBA classmates kind of joined force on this project, you know, as in its infancy, the UCLA, which, you know, venture accelerator, which was my, you know, first founder, basically, we, we came out of the incubator, equipped to talk to the world about our business case. And we got

17:09
$33,000 overnight from the business plan competition, NAP business plan competition, and the early UCLA founders who just showing overwhelming support. And we, in fact, we sold our product, first 25 units of our, you know, the digital otoscope in the early days before we graduated and gotten our first 100K of investor check before we graduated. So,

17:39
That was when we had to fund the company because we need to find a place to park the money as students part-time. So this was all full-time working, you know, professionals part-time on a weekend going to MBA. And then I, the past just went really interesting because of the pandemic. There was an overwhelming uptake of virtual care.

18:07
telehealth services, institutions who are looking at this new modality of care. And all of a sudden it was like, there were like 800 telehealth companies in the US at some point and they were all of our potential customers. We started co-calling them and we're getting quite a bit of feedback. In fact, many of them were working today. We are working with Rocket Doctor, for example. They've gotten, they've taken over half a million costs in the past couple of years.

18:35
in terms of virtual care services. They have sites at pharmacies and enabled stations of remote care for people who are not accessing an office in person. We are working with five school districts in five different states and these are school districts which leverage Remy for all of their nursing rooms and introducing it to their students and parents. And we are working

19:05
So we got very strong non-dilutive funding. Actually early days we had seed funding from Platinum Play, we have seed funding from United Healthcare Accelerator powered by Techstars. We had in-kind support from CTIP, which is consortium for technology and innovation in pediatrics, which is a large innovation, hospital innovation consortia of, I would say that's growing, you know,

19:34
at least children's hospitals in the West and Midwest. They are providing enormous support, including clinical collaborations, partnerships, granting services, regulatory guardrail, they're FDA-funded. So now we're working with them in terms of a clinical study site in Lowery Children's in Chicago, which is one of our primary sites

20:04
testing out not only REMI, Otoscopes, but REMI-AI, funded by the NIH, which is National Institute of Health under the Small Business Innovation and Research Grant at 3.5 million so far. So overall, there was overwhelming support also from my state, I'm from Washington. So the Life Science Institute of Washington also kind of invested. And last but not least,

20:32
I have to mention TIE, T-I-E, which is an angel funding investor group that has given us enormous support in terms of networking, in terms of fine tuning the business plans, mentorship sessions. It just goes on. There are a few other investors that we've been working with and overall we've raised about...

20:56
4.75 million in non-delutive funding, non-delutive, and then about another a million in the deletive. So this has gone into a clinical study phase where we're looking at success outcomes in terms of technology readiness, validation of performance of AI clearance through FDA as a class two device in a couple of years. And then commercially.

21:22
being able to facilitate telehealth services already. In addition to allowing the patients to see and examine, we're enabling physicians remotely examine and prescribe. And in the future, assisting both the physician and the patients in terms of prescription and receiving the accurate diagnosis. I'm looking at the, heading the all, I guess,

21:52
health care or the goals of health care today, the five aims, I believe, at least, you know, cutting costs, improving quality, increasing access. Yeah, all of that. Amazing. And as of today, so you've raised about 4.75 non dilutive, you're no longer raising dilutive funding until you get through the clinical trials. When will that be happening?

22:22
The study with Children's Hospital, Lurie Children's is happening now actually, so it's underway. And we are looking at in a year that we will have some tangible, really good results in terms of both the patient satisfaction, physicians demand and performance of the technology.

22:50
And what is the desired outcome? Because I got really excited too, because this will be maybe not the first, but one of the earliest FDA approved Class II devices jointly with AI, correct?

23:08
Yes, that's a very hot topic right now in terms of the use of AI, the governance of AI, who benefits from it and who pays for it. Ultimately, the AI that we are developing would be augmenting the physician's decision making.

23:33
in the meantime, directly benefiting the patients because they can potentially receive pre-screening alerts and results faster and earlier before they go or even while they're waiting for the physician's appointments. So I would say that the outcome, first and foremost, is the satisfaction of the patient and the physicians. We would like to work alongside with, you know, really

24:00
key influencer in the medical field, medically validating the performance and understanding the bias of the data. What would it be if we manipulate bias at one way or the other in terms of the algorithm development, right? Whether or not we're collecting comprehensive population-based data, have we looked at cases of

24:28
one way or the other, you know, like in general, understanding the algorithm development and the AI readout. I think there's a lot of misunderstanding about AI these days, right? People generalize it to be generative. But AI has been a concept that is, you know, it was a different name back then. It was data analysis, it was imaging analysis, it was big data. For a while, the algorithm is evolving, the capability is evolving.

24:57
Um, the, I guess before one investor was asking me, what, how do you handle data hallucination or AI hallucination, which basically means the AI is starting to give out fake results, um, based on ungrounded, um, facts or cheating or lying to you. Um, and there's also another different kind of AI, which was data driven or validated. Uh, it won't tell you anything that you don't tell it.

25:27
to, you know, it's kind of limited or confined to a set of outcomes. For us, it is the former at this point, it's less generative. We understand the ins and outs of the data that's going in and we know why it's, you know, spinning out the results while we are the other on the outcome, on the output side. I would say generative has got a lot of potential, but within health, healthcare, we just need to catch up a lot.

25:56
a lot faster for it to be widely applicable. Currently, is it fair to say that Remy does have the largest database of imaging within ENT?

26:11
We are one of the top in the world. The data size as the use case grows, as the user base grows would be growing. The data are aggregating and being applicable to algorithm training in an aggregation basis or the identified anonymized.

26:39
It's an interesting part about the platform we're building is the users can benefit and they know what their, they benefit early, you know, rather than just being, benefiting from AI telling them what to do or assisting them. They're benefiting from non-AI capabilities of the technology, facilitating their visits, shortening their distance from their pain to a prescription, for example, or diagnosis.

27:09
already, early on. So we sort of de-risk the path to AI. And AI becomes more of a later phase. But it is definitely going to augment and assist the human journey all in all. Excellent. And so while sticking with the actual platform, and one of the third elements that I was particularly interested in when

27:37
we did invest from the Thai fund was the lack of the shortage of primary care physicians, and specifically even pediatricians in the United States at this time. Talk to me a bit about how as the tech, that platform of Remy builds out, will this enable doctors will it substitute doctors? What's the what's the how will this address this?

28:06
actually, it's tsunami that is now on us of this shortage of doctors in such a common disease area. Yeah, yeah. I definitely think that it is a tsunami coming at us just from my experience of having to book out. My wild child checkup is like four months out. I was like, by the time I get my son's appointment for his 11 years old checkup, he's 12. Yeah, so just to give you.

28:36
idea and then I got a letter from my in the mail saying that I'm quitting, you know, my physician is quitting real life, right. So I basically think that the AI will be enabling the physicians to free up their time, you know, from some non acute or issues that they so in the meantime, providing the quality of care that patients need not to sacrifice the quality.

29:06
to free up their time and become more efficient in a way. Especially I can think about ER avoidance, right? As a big use case for Remy and referral pre-screening, right? Specialty referral pre-screening, both of those, you know, are gonna free up quite a bit of our, you know, healthcare resources in terms of leaving them for those acute cases and really needing, you know, attention of the physicians. Yeah.

29:35
ER avoidance, basically you go, before you go to the ER, while you're waiting in the ER, you can perform a test or some sort of a visit with Remy using the Remy technology and specialties per screening. Per screening could be like, while you're waiting for the specialist appointments, which might be three, four months out, you can get the insights that you need already. So both use cases, I think, will free up quite a bit of our time.

30:04
both from pediatricians, nurses, mid-level providers, and specialists, EV doctors and specialists. Oh, Remy. Can you, for my listeners, talk about where they can find Remy today?

30:22
Yeah, we are, we're in, on Amazon, if you search Remy, we are website, remyhouse.com. We have a very convenient e-commerce, shipping and handling protocols. So you should be able to order on Friday, receive on Monday, for example, or even faster than that. And then we are, we are at your clinic. We're maybe at your clinic, maybe at your school district, we are working with a few of these.

30:52
physicians, clinics, there are logos on our website. If you're one of the patients of the clinics, you will get these at a discount, easily accessible rate. And if you visit us at the exhibits, in terms of commercial and marketing exposures, we are gonna be at Medica in Germany. That is next week, November 11th to 14th.

31:20
in Dusseldorf in Germany, we are part of the Washington State Pavilion to exhibit there. And then we are publishing, you know, academically we are collaborating with United, sorry, University of Southern California, USC in the speech and speech hearing and language pathologist community, especially in collaboration with USC.

31:50
We are publishing a poster there that's going to be December 5 to 7 in Seattle, Washington. Excellent. Let's switch to the founder sandbox. I'm passionate about working with company owners on their purpose, their scalability and their resilience. And I have a founder here in the sandbox with me today.

32:18
You're into what your sixth year of being a CEO. Tell me, what does resilience mean to you? Jane.

32:31
Oh my gosh, there are so many places you just have to hold on to. Hold on to the idea. I think first and foremost, it's something that you believe. There is some belief that this is there. You know, like it's worth your time. It's worth the effort. It's worth. Keep going. Right. So if you give up, it's it's probably you don't believe in it enough. Right. At some point, because of, you know, all the failures and problems that comes up.

33:02
Yeah, don't get me started. And then the belief is there. I think this is the future, the calling. It's historically inevitable, right? If it's Remy or someone else, it should be done, right? So that's my belief. And it's driven me every day when I wake up. And then when I think about resilience, I also think about when I'm fundraising, talking to investors, I get...

33:31
99% knows, right? And then 1%, yes. But does that mean that I'm not a good company, a good founder? No, it just means we're not good fit, right? Like investors have their own thesis, their goals to fill, their speed, stage of company, check sizes, everything has to meet perfectly. And even personality wise, those investors are gonna be with you for a while. You trust each other.

34:00
So that's fundraising. And then just keep going at it. And product wise, people say no to my product. Oftentimes for various reasons, customers are always right. Again, does that mean that I'm not a good product or services? No, the more I talk to them, the more nos I get, the more yes I will get as well. So again, that's sort of on the market research or understanding the general

34:30
target, you know, like as you're looking for the product market fit, you know, again, the keyword here is fit. And then the third piece is, is just just interpersonal, you know, like, people, oftentimes, I mean, like or dislike each other for a reason. And there's nothing wrong with, you know, knowing

34:56
knowing more getting more so I have a very big mentor mentor community I reach out to them every time I need an answer and they're just all willing to help that really helps with the mentality the the resilience as well you know I know I'm being supported I know I know people love me like my products are being loved my services are needed and my mentors really support me so that's that's what really helps with the positivity yeah excellent thank you for those four nuggets

35:26
your own words about what resilience means to you. Thank you for talking about your product and believing in the future of telehealth with Remy or not. It's very, very humble. And I loved, so the key word is fit, right? Fit with your investor, fit with your customers, what they're wanting, fit with the belief. Take that to the next.

35:55
question, fit or purpose driven? Are you fit for purpose? What is purpose driven enterprise? All right, so this this goes beyond the resilience to enterprise. Purpose driven, what's that mean to you?

36:09
I think I started the journey caring about sort of mental house of women, you know, that's like, you know, besides children's health, health, right. So, and I spent my whole journey, whole research doing underserved community health diagnostics, right. So I've been working on, you know, the

36:36
the worst diseases you can think about HIV, tuberculosis, these pathology pathogens, right? I was kind of in a class three bio lab, working while I was pregnant, tuberculosis. So you name it, right? Like any sort of crazy things that happen to people, I have really strong sort of desire to

37:05
help them or address it. Also something that's probably rooted in my family. You know, like I don't talk about that a whole lot, but my dad came out of sort of this pure poverty, right? Like he, my grandpa was a shepherd and he sort of, I guess long story short, my dad was also kind of a, would be a beneficiary of Remy. He had a perforated eardrum because he listened to

37:34
English radios too much before he came to UK for study, you know, as a first generation college student from his family. So nowadays he still has a deaf ear, right, like perforated eardrums. So I'm still thinking, you know, is there something I can do for him? But overall, I felt as a, like, just to echo where I started in the beginning, you know, as a woman in the prime years of, you know, career.

38:04
you know, where I wanted to be, you know, I was earning good money, I was having a good corporate job, I was caring for my child, you know, which really kind of pampered my productivity at work. I think that's kind of an issue that nobody really talks about because everybody wants top performers, you know, like you need to be working when your child is sick or something like that. But, you know, overall, it's kind of

38:30
issue that's there and near to my heart as women and children's health, especially for underserved communities. Thank you. Thank you, Jane.

38:41
Wow. Scalable growth. Take that resilience plus your purposefulness and scale it. Is it truly what the platform will become scalable? What does scalable mean to you?

39:11
how, you know, help the physicians in a way. You will, I will scale really well if I can, you know, bring benefits to ease their work, ease their stress at work. There are patients coming in, they're getting text messages from the patient, hey, what's going on with me if I can see this image? I was like, that's crazy. Like, how do you respond to that, right? Like in a way that polite and shows that you're a human, you care, but if you get 300 of those a day, how do you...

39:40
How do you do that? And then they say, oh, they send them to my charts. Again, that's losing or like the patient just waiting. How do you address this mismatch of having physicians providing care at top quality and efficiency while being a human to the patients and then the patients are satisfied and getting the needs met. I'm trying to make my story.

40:10
or resonating with physicians that they can be, just to give you an example, right? A physician mentioned that 50% of my, this was a specialist who said 50% of the patients who came to me should not have been in my office because I wanted to help those who can, they need me for a procedure most of the time. If they come to me for diagnostics confirmation, I could have done that.

40:40
with their information gathered in front of me already, before they come. So that's kind of the point. And it's almost like whenever they're open or free, aggregating physicians time across all these physicians who have time, whenever they have time to care for patients aggregated across all these issues, whenever they have an issue, we're trying to build sort of a bridge

41:11
the aggregation would really help address the problem of mismatch of asynchronous visits or waiting and not getting the answers. I don't know if that's too abstract. No, I get it. And you know what? Kind of along the lines of purpose, your purpose, caring about mental health for mothers, you also by the adoption of Remy Health in settings with the patients using it from home.

41:41
or being screened early on, you're clearly affecting the mental health of our caregivers, our physicians. And we do know that tsunamis here, there's a high level of attrition. Doctors actually just quitting. And if through tech enabled or AI powered, intelligent aggregation of data informs the decisions to reduce number of visits.

42:10
or have them more productive while in the setting, the clinical setting can move the needle, so be it. So thank you, Jane. This has been absolutely an amazing interview. I have one last question. Did you have fun in the sandbox today? Yes.

42:33
Absolutely, Randa. I really, really appreciate the opportunity. It's wonderful to every time I talk to you, it's wonderful, but especially interesting when we're like in this setting and you know, podcasting to more to a greater audience and really appreciate what you do for the community. Thank you. Thank you. So to my listeners, if you'd like this episode with Jane Tseng, CEO of Remy,

43:03
resilience and scalable and purpose-driven life story, as well as the origin story, as well as the product. Remy, sign up for the monthly release where founders and business owners, corporate directors and professional service providers provide their own stories on how to build with strong governance, a resilient, scalable and purpose-driven company to make profits for good.

43:32
Sign off for this month. Thank you for joining us.